We are live on
!
Find out more
Holocene Advisors Portfolio holdings
AUM
$41.5B
1-Year Est. Return
42.97%
This Fund
S&P 500
This Quarter
Est. Return
-0.82%
1 Year Est. Return
+42.97%
3 Year Est. Return
+132.57%
5 Year Est. Return
+195.68%
10 Year Est. Return
–
AUM
$24B
AUM Growth
-$3.28B
(-12%)
Cap. Flow
-$2.78B
Cap. Flow
% of AUM
-11.61%
Top 10 Holdings %
Top 10 Hldgs %
17.42%
Holding
884
New
192
Increased
181
Reduced
295
Closed
209
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$702M |
| 2 |
PepsiCo
PEP
|
+$352M |
| 3 |
Merck
MRK
|
+$320M |
| 4 |
Murphy USA
MUSA
|
+$254M |
| 5 |
Autodesk
ADSK
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$407M |
| 2 |
Target
TGT
|
+$346M |
| 3 |
Meta Platforms (Facebook)
META
|
+$302M |
| 4 |
Broadcom
AVGO
|
+$274M |
| 5 |
CarMax
KMX
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.12% |
| 2 | Consumer Discretionary | 16.62% |
| 3 | Technology | 15.43% |
| 4 | Industrials | 11.09% |
| 5 | Consumer Staples | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
76
DELISTED
Blueprint Medicines
BPMC
| $102M | 0.42% |
943,464
+228,161
| +32% | +$22.8M |
|
|
ITCI
77
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $101M | 0.42% |
1,479,675
+570,585
| +63% | +$39.6M |
|
78
Chevron
CVX
$371B
| $101M | 0.42% |
642,507
+623,575
| +3,294% | +$99.4M |
|
79
Walmart Inc
WMT
$894B
| $99.1M | 0.41% |
+1,463,141
| New | +$92.1M |
|
80
Brinker International
EAT
$9.69B
| $97.5M | 0.41% |
1,347,280
-1,368,327
| -50% | -$81.5M |
|
81
Diamondback Energy
FANG
$52.4B
| $96.2M | 0.4% |
480,578
-281,629
| -37% | -$55.9M |
|
82
Tesla
TSLA
$1.27T
| $94.5M | 0.39% |
+477,367
| New | +$83.4M |
|
83
CBRE Group
CBRE
$43.8B
| $94.3M | 0.39% |
1,058,707
+489,423
| +86% | +$43.4M |
|
|
MRUS
84
DELISTED
Merus
MRUS
| $93.1M | 0.39% |
1,573,866
+634,290
| +68% | +$30.7M |
|
85
NetApp
NTAP
$36.6B
| $90.7M | 0.38% |
+704,429
| New | +$79.1M |
|
86
Bank of America
BAC
$442B
| $90.5M | 0.38% |
2,274,630
+780,187
| +52% | +$29.9M |
|
87
Canadian Pacific Kansas City
CP
$80.4B
| $87.5M | 0.37% |
+1,111,123
| New | +$90.4M |
|
88
Freeport-McMoran
FCX
$99.8B
| $87.4M | 0.36% |
1,797,862
-1,735,411
| -49% | -$87.5M |
|
89
Revolution Medicines
RVMD
$41.9B
| $85.5M | 0.36% |
2,203,474
-218,937
| -9% | -$8.18M |
|
90
SLB Ltd
SLB
$74.1B
| $84.4M | 0.35% |
+1,788,094
| New | +$86.3M |
|
91
Snowflake
SNOW
$110B
| $84M | 0.35% |
+622,121
| New | +$91.9M |
|
92
DraftKings
DKNG
$10.8B
| $80.8M | 0.34% |
+2,115,886
| New | +$87.8M |
|
93
Royal Caribbean
RCL
$87.6B
| $78.6M | 0.33% |
492,879
-608,124
| -55% | -$87.4M |
|
94
Thermo Fisher Scientific
TMO
$214B
| $78.3M | 0.33% |
141,635
+60,447
| +74% | +$34.6M |
|
95
Lockheed Martin
LMT
$133B
| $77.5M | 0.32% |
165,987
+159,069
| +2,299% | +$73.5M |
|
96
Mastercard
MA
$500B
| $75.1M | 0.31% |
170,179
+42,509
| +33% | +$19.4M |
|
97
Teva Pharmaceuticals
TEVA
$40.5B
| $74.5M | 0.31% |
4,586,272
-376,184
| -8% | -$5.79M |
|
98
MongoDB
MDB
$30.3B
| $74M | 0.31% |
+295,873
| New | +$93.4M |
|
99
Dyne Therapeutics
DYN
$4.89B
| $73.3M | 0.31% |
+2,076,352
| New | +$60.3M |
|
100
TSMC
TSM
$2.15T
| $72.9M | 0.3% |
419,149
-975,583
| -70% | -$148M |
|
Similar funds
DB
HF
Holocene Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Holocene Advisors held 884 positions worth $24B, down 12% from $27.2B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Holocene Advisors withdrew a net $2.78B in Q2 2024, closing 209 positions and reducing 295 holdings. Its most notable exit was Target, an estimated $346M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Holocene Advisors opened a new position in PepsiCo worth $336M.
- Holocene Advisors's largest Q2 2024 buy was PepsiCo: 2,038,750 shares worth $336M.
- Holocene Advisors added most to Visa in Q2 2024, an estimated $702M increase.
- Holocene Advisors's biggest Q2 2024 reduction was Microsoft, cutting an estimated $407M.
- Holocene Advisors fully exited Target in Q2 2024, selling an estimated $346M.
- Holocene Advisors's ten largest holdings make up 17% of its $24B portfolio in Q2 2024.
- Holocene Advisors opened 192 new positions and closed 209 in Q2 2024.
- Holocene Advisors's portfolio value fell 12% quarter-over-quarter to $24B.
Based on Holocene Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.